Natural Investments LLC acquired a new stake in Danaher Co. (NYSE:DHR - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,351 shares of the conglomerate's stock, valued at approximately $998,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. AGF Management Ltd. increased its stake in shares of Danaher by 1.6% in the fourth quarter. AGF Management Ltd. now owns 8,940 shares of the conglomerate's stock valued at $2,052,000 after buying an additional 140 shares in the last quarter. Avantax Planning Partners Inc. boosted its holdings in Danaher by 32.2% during the fourth quarter. Avantax Planning Partners Inc. now owns 2,572 shares of the conglomerate's stock worth $590,000 after buying an additional 626 shares during the last quarter. Eos Management L.P. lifted its holdings in shares of Danaher by 18.4% during the 4th quarter. Eos Management L.P. now owns 26,030 shares of the conglomerate's stock valued at $5,975,000 after purchasing an additional 4,052 shares in the last quarter. Davis R M Inc. lifted its holdings in shares of Danaher by 0.4% during the 4th quarter. Davis R M Inc. now owns 327,516 shares of the conglomerate's stock valued at $75,181,000 after purchasing an additional 1,467 shares in the last quarter. Finally, Independent Advisor Alliance lifted its stake in Danaher by 27.7% in the 4th quarter. Independent Advisor Alliance now owns 5,282 shares of the conglomerate's stock valued at $1,212,000 after acquiring an additional 1,145 shares in the last quarter. 79.05% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of research analysts recently weighed in on DHR shares. Wells Fargo & Company decreased their target price on Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a report on Thursday, January 30th. Robert W. Baird lowered their target price on Danaher from $277.00 to $268.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Barclays decreased their price target on Danaher from $275.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. Scotiabank began coverage on Danaher in a research note on Monday, December 23rd. They set a "sector perform" rating and a $265.00 target price for the company. Finally, Citigroup cut their price target on Danaher from $285.00 to $265.00 and set a "buy" rating on the stock in a report on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $278.00.
Check Out Our Latest Report on Danaher
Insider Transactions at Danaher
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company's stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 11.10% of the company's stock.
Danaher Price Performance
NYSE DHR opened at $206.01 on Wednesday. The company has a market capitalization of $147.24 billion, a PE ratio of 39.02, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The business's fifty day moving average is $221.55 and its 200 day moving average is $241.74. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70.
Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the business earned $2.09 EPS. Sell-side analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. This is a boost from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher's payout ratio is 24.24%.
About Danaher
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
